Dr Wolfe is a seasoned biotechnology start-up entrepreneur contributing expertise in biopharmaceutical development, clinical research, bioengineering, intellectual property, strategic planning and business administration. Dr Wolfe is an inventor of several platform intellectual property portfolios. Prior to joining Sidero, he founded and was President & CEO of PeriphaGen Holdings, a biotechnology company focused on the development of novel gene therapies targeting the human nervous system. Previously, Dr Wolfe advanced to become President & CEO of Diamyd Incorporated and directed business development, preclinical, clinical, legal, and financial activities of the company. Dr Wolfe has over 60 scientific publications on a variety of medical development areas and has been awarded numerous patents and federal grants.